日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Epigenetic activation of EBV BGLF4 determines antiviral-based regimen response in EBV+CNS lymphoproliferative disease

EBV BGLF4 的表观遗传激活决定 EBV 阳性中枢神经系统淋巴增生性疾病的抗病毒治疗方案反应。

Weigel, Christoph; Klimaszewski, Haley L; Tounkara, Fode; Addissie, Selamawit; Schlotter, Sarah; Pray, Betsy; Dugan, James P; Haverkos, Bradley M; Villagomez, Lynda; Lustberg, Mark; Porcu, Pierluigi; Voorhees, Timothy; Ambinder, Richard F; Kenney, Shannon C; Fingeroth, Joyce; Delecluse, Henri-Jacques; Caligiuri, Michael A; Alinari, Lapo; Bumgardner, Ginny; Oakes, Christopher C; Baiocchi, Robert A

IRF6 controls Epstein-Barr virus (EBV) lytic reactivation and differentiation in EBV-infected epithelial cells.

IRF6 控制 Epstein-Barr 病毒 (EBV) 的裂解性再激活和 EBV 感染的上皮细胞的分化

Fogarty Stuart A, Singh Deo R, Nelson Scott E, Calandranis Maria E, Zhang Yitao, Pawelski Abigail S, Kansra Alisha S, White Sophie, Kenney Shannon C

Epstein-Barr virus type 2 infection is associated with higher viral loads in pediatric tonsils from western Kenya

肯尼亚西部儿童扁桃体中,Epstein-Barr病毒2型感染与较高的病毒载量相关。

Koech, Emmily; Ogolla, Sidney; Amolo, Asito S; Waomba, Kevin; Onditi, Ian; Sabourin, Katherine R; Ariera, Bonface; Chumbe, Stellah; Kenney, Shannon C; Rochford, Rosemary; Samayoa-Reyes, Gabriela

Development and Preclinical Evaluation of [(64)Cu]Cu-NOTA-ABDB6: A CD70 and Albumin Dual-Binding Tracer with Improved Pharmacokinetics

[(64)Cu]Cu-NOTA-ABDB6 的开发和临床前评价:一种具有改进药代动力学的 CD70 和白蛋白双重结合示踪剂

Li, Xiaoyan; Zhang, You; Mixdorf, Jason C; Wu, Qianyun; Lee, Sophia J; Engle, Jonathan W; Barnhart, Todd E; Kenney, Shannon C; Rui, Lixin; Wei, Weijun; Cai, Weibo

Human CD4(+) iNKT cell adoptive immunotherapy induces anti-tumour responses against CD1d-negative EBV-driven B lymphoma

人CD4(+) iNKT细胞过继免疫疗法可诱导针对CD1d阴性EBV驱动的B淋巴瘤的抗肿瘤反应

Baiu, Dana C; Sharma, Akshat; Schehr, Jennifer L; Basu, Jayati; Smith, Kelsey A; Ohashi, Makoto; Johannsen, Eric C; Kenney, Shannon C; Gumperz, Jenny E

Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ

Epstein-Barr病毒LMP1蛋白通过激活YAP和TAZ促进上皮细胞增殖并抑制其分化。

Singh, Deo R; Nelson, Scott E; Pawelski, Abigail S; Kansra, Alisha S; Fogarty, Stuart A; Bristol, Jillian A; Ohashi, Makoto; Johannsen, Eric C; Kenney, Shannon C

Epstein-Barr virus: Biology and clinical disease

爱泼斯坦-巴尔病毒:生物学和临床疾病

Damania, Blossom; Kenney, Shannon C; Raab-Traub, Nancy

B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection

与1型EB病毒感染相比,2型EB病毒感染的B细胞具有更高的NFATc1/NFATc2活性和更强的裂解基因表达。

Romero-Masters, James C; Huebner, Shane M; Ohashi, Makoto; Bristol, Jillian A; Benner, Bayleigh E; Barlow, Elizabeth A; Turk, Gail L; Nelson, Scott E; Baiu, Dana C; Van Sciver, Nicholas; Ranheim, Erik A; Gumperz, Jenny; Sherer, Nathan M; Farrell, Paul J; Johannsen, Eric C; Kenney, Shannon C

Development of a novel inducer for EBV lytic therapy

开发一种新型的EBV裂解疗法诱导剂

Tikhmyanova, Nadezhda; Paparoidamis, Nicholas; Romero-Masters, James; Feng, Xin; Mohammed, Farheen Sultana; Reddy, Poli Adi Narayana; Kenney, Shannon C; Lieberman, Paul M; Salvino, Joseph M

Complete and Durable Responses in Primary Central Nervous System Posttransplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab, and Dexamethasone

齐多夫定、更昔洛韦、利妥昔单抗和地塞米松治疗原发性中枢神经系统移植后淋巴增殖性疾病可获得完全且持久的缓解

Dugan, James P; Haverkos, Bradley M; Villagomez, Lynda; Martin, Ludmila K; Lustberg, Mark; Patton, John; Martin, Marisa; Huang, Ying; Nuovo, Gerard; Yan, Fengting; Cavaliere, Robert; Fingeroth, Joyce; Kenney, Shannon C; Ambinder, Richard F; Lozanski, Gerard; Porcu, Pierluigi; Caligiuri, Michael A; Baiocchi, Robert A